The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

OBI-902 is the first ADC utilizing OBI’s proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / ...

A large international study of more than 23,000 patients has found that common medicines used to treat high blood pressure ...

The FDA recently approved a pretzel-shaped implant that helps some bladder cancer patients keep their bladder. Dr. Chris ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...